#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Allison Hulme Email
CEO . Aeovian Pharmaceuticals
Berkeley, CA
LocationPrimary Email
How to contact Allison Hulme
Join and see Allison's contact info for free!Phone
Current Roles
Employees:
11Revenue:
$0About
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.\n\nOur lead development candidate, AV078, is a first-in-class CNS penetrant selective mTORC1 inhibitor being developed for the treatment of TSC refractory epilepsy and is currently being evaluated in a Phase 1 trial. TSC is a rare genetic disorder caused by the hyperactive signaling of mTORC1.\n\nBeyond AV078, we’ve developed a proprietary library of small molecules, which are potent and selective mTORC1 and CD38 inhibitors that have the potential to precisely target the underlying biology of multiple rare and age-related diseaseAeovian Pharmaceuticals Address
Berkeley, CA
United States